Trxade Group (NASDAQ: MEDS) announced that the
company’s chief executive officer Suren Ajjarapu will ring the Nasdaq opening
bell at 9:30 AM ET on February 28, 2020, signifying the start of trade. Trxade
Group is an integrated drug procurement, delivery and healthcare platform that
enables price transparency and increased profit margins to healthcare buyers
and sellers of pharmaceuticals. The company’s common stock began trading on the
Nasdaq Capital Market under its new symbol ‘MEDS’ on February 13, 2020.
To view the full press release, visit http://ibn.fm/fCKGu
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ:
MEDS) is an integrated drug procurement, delivery and healthcare platform that
enables price transparency and increased profit margins to healthcare buyers
and sellers of pharmaceuticals. Founded in 2010, Trxade Group is comprised of
three synergistic operating platforms; the Trxade B2B trading platform with
11,900 registered pharmacies, licensed virtual Wholesale and Mail Order
Pharmacy delivery capabilities using DelivMeds app. For additional information,
please visit www.Trxade.com.
NOTE TO INVESTORS: The latest news and updates
relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission Investor
Relations website applicable to all content provided by MIR, wherever published
or re-published: http://www.missionir.com/disclaimer.html
